Leveraging the Tumor Microenvironment for IO Therapy - a podcast by Pharma Talk Radio

First recorded at the 4th annual IO Combinations 360° conference, this talk provided by Dr Kenneth Hance, GSK addresses agonistic strategies, T and NK cell redirection and the use of genetic/phenotypic assocations to identify novel target space in IO.

To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Further episodes of PharmaTalkRadio

Further podcasts by Pharma Talk Radio

Website of Pharma Talk Radio